Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design
- PMID: 19796713
- DOI: 10.1016/j.bbapap.2009.09.022
Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design
Abstract
At the first glance CK2alpha, the catalytic subunit of protein kinase CK2, is a rigid molecule: in contrast to many eukaryotic protein kinases in CK2alpha the canonical regulatory key elements like the activation segment occur exclusively in their typical active conformations. This observation fits well to the constitutive activity of the enzyme, meaning, its independence from phosphorylation or other characteristic control factors. Most CK2alpha structures are based on the enzyme from Zea mays, supplemented by an increasing number of human CK2alpha structures. In the latter a surprising plasticity of important ATP-binding elements - the interdomain hinge region and the glycine-rich loop - was discovered. In fully active CK2alpha the hinge region is open and does not anchor the ATP ribose, but alternatively it can adopt a closed conformation, form hydrogen bonds to the ribose moiety and thus retract the gamma-phospho group from its functional position. In addition to this partially inactive state human CK2alpha was recently found in a fully inactive conformation. It is incompatible with ATP-binding due to a combination of a closed hinge and a collapse of the glycine-rich loop into the ATP cavity. These conformational transitions are apparently correlated with the occupation state of a remote docking site located at the interface to the non-catalytic subunit CK2beta: if CK2beta blocks this site, the fully active conformation of CK2alpha is stabilized, while the binding of certain small molecule seems to favour the partially and fully inactive states. This observation may be exploited to design effective and selective CK2 inhibitors.
Copyright 2009 Elsevier B.V. All rights reserved.
Similar articles
-
First inactive conformation of CK2 alpha, the catalytic subunit of protein kinase CK2.J Mol Biol. 2009 Mar 13;386(5):1212-21. doi: 10.1016/j.jmb.2009.01.033. Epub 2009 Jan 24. J Mol Biol. 2009. PMID: 19361447
-
Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit.J Mol Biol. 2003 Jul 25;330(5):925-34. doi: 10.1016/s0022-2836(03)00638-7. J Mol Biol. 2003. PMID: 12860116
-
Structure of the human protein kinase CK2 catalytic subunit CK2α' and interaction thermodynamics with the regulatory subunit CK2β.J Mol Biol. 2011 Mar 18;407(1):1-12. doi: 10.1016/j.jmb.2011.01.020. Epub 2011 Jan 15. J Mol Biol. 2011. PMID: 21241709
-
Protein kinase CK2 in health and disease: Protein kinase CK2: from structures to insights.Cell Mol Life Sci. 2009 Jun;66(11-12):1800-16. doi: 10.1007/s00018-009-9149-8. Cell Mol Life Sci. 2009. PMID: 19387553 Free PMC article. Review.
-
Protein kinase CK2 in health and disease: Structural bases of protein kinase CK2 inhibition.Cell Mol Life Sci. 2009 Jun;66(11-12):1868-89. doi: 10.1007/s00018-009-9155-x. Cell Mol Life Sci. 2009. PMID: 19387547 Free PMC article. Review.
Cited by
-
Structural and functional insights into the regulation mechanism of CK2 by IP6 and the intrinsically disordered protein Nopp140.Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19360-5. doi: 10.1073/pnas.1304670110. Epub 2013 Nov 11. Proc Natl Acad Sci U S A. 2013. PMID: 24218616 Free PMC article.
-
Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation.Mol Cell Pharmacol. 2014;6(2):15-25. Mol Cell Pharmacol. 2014. PMID: 25893034 Free PMC article.
-
Predictive functional, statistical and structural analysis of CSNK2A1 and CSNK2B variants linked to neurodevelopmental diseases.Front Mol Biosci. 2022 Oct 13;9:851547. doi: 10.3389/fmolb.2022.851547. eCollection 2022. Front Mol Biosci. 2022. PMID: 36310603 Free PMC article.
-
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action.J Med Chem. 2019 Feb 28;62(4):1817-1836. doi: 10.1021/acs.jmedchem.8b01765. Epub 2019 Feb 13. J Med Chem. 2019. PMID: 30689946 Free PMC article.
-
Structural and functional determinants of protein kinase CK2α: facts and open questions.Mol Cell Biochem. 2011 Oct;356(1-2):67-73. doi: 10.1007/s11010-011-0939-6. Epub 2011 Jul 8. Mol Cell Biochem. 2011. PMID: 21739155 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources